Analysis of clinical features and outcomes in patients with ocular myasthenia gravis according to anti-acetylcholine receptor antibody-seropositivity

Grob D, Brunner N, Namba T, Pagala M. Lifetime course of myasthenia gravis. Muscle Nerve. 2008;37:141–9.

Article  PubMed  Google Scholar 

Galassi G, Mazzoli M, Ariatti A, Kaleci S, Valzania F, Nichelli PF. Antibody profile may predict outcome in ocular myasthenia gravis. Acta Neurol Belg. 2018;118:435–43.

Article  PubMed  Google Scholar 

Nagaishi A, Narita T, Woodhall M, Jacobson L, Waters P, Irani SR, et al. Autoantibodies in Japanese patients with ocular myasthenia gravis. Muscle Nerve. 2021;63:262–7.

Article  CAS  PubMed  Google Scholar 

Birmanns B, Brenner T, Abramsky O, Steiner I. Seronegative myasthenia gravis: clinical features, response to therapy and synthesis of acetylcholine receptor antibodies in vitro. J Neurol Sci. 1991;102:184–9.

Article  CAS  PubMed  Google Scholar 

Evoli A, Batocchi AP, Lo Monaco M, Servidei S, Padua L, Majolini L, et al. Clinical heterogeneity of seronegative myasthenia gravis. Neuromuscul Disord. 1996;6:155–61.

Article  CAS  PubMed  Google Scholar 

Guterman EL, Botelho JV, Horton JC. Diagnosis of Tensilon-negative ocular myasthenia Gravis by Daily Selfie. J Neuroophthalmol. 2016;36:292–3.

Article  PubMed  PubMed Central  Google Scholar 

Mao ZF, Yang LX, Mo XA, Qin C, Lai YR, He NY, et al. Frequency of autoimmune diseases in myasthenia gravis: a systematic review. Int J Neurosci. 2011;121:121–9.

Article  PubMed  Google Scholar 

Kubiszewska J, Szyluk B, Szczudlik P, Bartoszewicz Z, Dutkiewicz M, Bielecki M, et al. Prevalence and impact of autoimmune thyroid disease on myasthenia gravis course. Brain Behav. 2016;6:e00537.

Article  PubMed  PubMed Central  Google Scholar 

Ratanakorn D, Vejjajiva A. Long-term follow-up of myasthenia gravis patients with hyperthyroidism. Acta Neurol Scand. 2002;106:93–8.

Article  CAS  PubMed  Google Scholar 

Sahay BM, Blendis LM, Greene R. Relation between myasthenia gravis and thyroid disease. Br Med J. 1965;1:762–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kiessling WR, Pflughaupt KW, Ricker K, Haubitz I, Mertens HG. Thyroid function and circulating antithyroid antibodies in myasthenia gravis. Neurology. 1981;31:771–4.

Article  CAS  PubMed  Google Scholar 

Toth C, McDonald D, Oger J, Brownell K. Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid disease. Acta Neurol Scand. 2006;114:124–32.

Article  CAS  PubMed  Google Scholar 

Lopomo A, Berrih-Aknin S. Autoimmune thyroiditis and Myasthenia Gravis. Front Endocrinol (Lausanne). 2017;8:169.

Article  PubMed  Google Scholar 

Sun L, Meng Y, Xie Y, Zhang H, Zhang Z, Wang X, et al. CTLA4 variants and haplotype contribute genetic susceptibility to myasthenia gravis in northern Chinese population. PLoS ONE. 2014;9:e101986.

Article  PubMed  PubMed Central  Google Scholar 

Claytor B, Li Y. Challenges in diagnosing coexisting ocular myasthenia gravis and thyroid eye disease. Muscle Nerve. 2021;63:631–9.

Article  PubMed  Google Scholar 

Vargas ME, Warren FA, Kupersmith MJ. Exotropia as a sign of myasthenia gravis in dysthyroid ophthalmopathy. Br J Ophthalmol. 1993;77:822–3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chatzistefanou KI, Kouris T, Iliakis E, Piaditis G, Tagaris G, Katsikeris N, et al. The ice pack test in the differential diagnosis of myasthenic diplopia. Ophthalmology. 2009;116:2236–43.

Article  PubMed  Google Scholar 

An R, Li Y, Yang B, Wang H, Xu Y. Rare co-occurrence of ocular myasthenia gravis and thyroid-Associated Orbitopathy (Ophthalmopathy) in an individual with hypothyroidism. Front Endocrinol (Lausanne). 2018;9:801.

Article  PubMed  Google Scholar 

Evoli A, Bianchi MR, Riso R, Minicuci GM, Batocchi AP, Servidei S, et al. Response to therapy in myasthenia gravis with anti-MuSK antibodies. Ann N Y Acad Sci. 2008;1132:76–83.

Article  CAS  PubMed  Google Scholar 

Hamedani AG, Pistilli M, Singhal S, Shindler KS, Avery RA, Tamhankar MA. Outcomes after Transcervical Thymectomy for Ocular Myasthenia gravis: a Retrospective Cohort Study with Inverse Probability Weighting. J Neuroophthalmol. 2020;40:8–14.

Article  PubMed  PubMed Central  Google Scholar 

Roberts PF, Venuta F, Rendina E, De Giacomo T, Coloni GF, Follette DM, et al. Thymectomy in the treatment of ocular myasthenia gravis. J Thorac Cardiovasc Surg. 2001;122:562–8.

Article  CAS  PubMed  Google Scholar 

Liu X, Zhou W, Hu J, Hu M, Gao W, Zhang S, Zeng W. Prognostic predictors of remission in ocular myasthenia after thymectomy. J Thorac Dis. 2020;12:422–30.

Article  PubMed  PubMed Central  Google Scholar 

Peeler CE, De Lott LB, Nagia L, Lemos J, Eggenberger ER, Cornblath WT. Clinical utility of acetylcholine receptor antibody testing in Ocular Myasthenia Gravis. JAMA Neurol. 2015;72:1170–4.

Article  PubMed  PubMed Central  Google Scholar 

Comments (0)

No login
gif